J&J also raised its full-year revenue guidance to include sales of the psychiatric drug Caplyta, which the company got from ...

Find out why Europe has fallen behind the U.S. and China in the AI race in biotech and what it needs to do to catch up.

Stock market whiplash is dampening hopes for a comeback year in the biotech arena. Roughly 25% of biotech stock values sank below their cash holdings last week amid sudden changes to U.S. trade policy ...

Employment in the U.S. life sciences sector hit a record high in 2024, and more job growth is expected in 2025.

History: The building is part of the second phase of the Chandler Airpark 202 business park, a 397,177-square-foot industrial ...

Merck licenses Cyprumed's oral drug delivery platform in $493M deal to develop oral peptide formulations, potentially for GLP-1 drugs.

On April 1, 2025, the Secretary of Commerce initiated, pursuant to President Trump’s directive, two new investigations under ...

A new report ranks the best college towns in the U.S. for 2025—and the No. 1 spot might surprise you. From affordability to ...

He should explain how his cuts will protect American innovation and benefit patients. Otherwise, the public might reasonably ...

President Donald Trump and his administration are laying the groundwork to invoke national security to impose a new tax on pharmaceuticals and semiconductors.

DBS Bank dominates LinkedIn's 2025 Top Companies in Singapore list for the third time in a row, topping the best companies for career growth in the country.

Mural Oncology plc said on Tuesday it would stop clinical development of its lead cancer treatment, nemvaleukin, and look into strategic alternatives for the company.